Pinnacle Bancorp, Inc. Abb Vie Inc. Transaction History

Pinnacle Bancorp, Inc.

$370 Million
Q3 2024

A detailed history of Pinnacle Bancorp, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Pinnacle Bancorp, Inc. holds 13,096 shares of ABBV stock, worth $2.3 Million. This represents 0.7% of its overall portfolio holdings.

Number of Shares

13,096

Previous 13,164 0.52%

Holding current value

$2.3 Million

Previous $2.26 Million 14.58%

% of portfolio

0.7%

Previous 0.67%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 09, 2024	SELL	$163.84 - $199.33 $11,141 - $13,554	-68 Reduced 0.52%	13,096 $2.59 Million
Q2 2024 Jul 15, 2024	SELL	$154.79 - $180.76 $109,591 - $127,978	-708 Reduced 5.1%	13,164 $2.26 Million
Q4 2023 Jan 25, 2024	SELL	$137.6 - $154.97 $66,048 - $74,385	-480 Reduced 3.34%	13,872 $2.15 Million
Q3 2023 Oct 18, 2023	SELL	$133.59 - $154.65 $4,007 - $4,639	-30 Reduced 0.21%	14,352 $2.14 Million
Q2 2023 Jul 13, 2023	BUY	$132.51 - $164.9 $61,219 - $76,183	462 Added 3.32%	14,382 $1.94 Million
Q1 2023 Apr 14, 2023	BUY	$144.61 - $166.54 $33,838 - $38,970	234 Added 1.71%	13,920 $2.22 Million
Q4 2022 Jan 24, 2023	SELL	$138.31 - $165.87 $117,978 - $141,487	-853 Reduced 5.87%	13,686 $2.21 Million
Q3 2022 Oct 25, 2022	BUY	$134.21 - $153.93 $21,607 - $24,782	161 Added 1.12%	14,539 $1.95 Million
Q2 2022 Jul 12, 2022	SELL	$137.62 - $174.96 $90,278 - $114,773	-656 Reduced 4.36%	14,378 $2.2 Million
Q1 2022 Apr 14, 2022	BUY	$131.98 - $163.75 $48,040 - $59,605	364 Added 2.48%	15,034 $2.44 Million
Q4 2021 Jan 19, 2022	BUY	$107.43 - $135.93 $9,883 - $12,505	92 Added 0.63%	14,670 $1.99 Million
Q3 2021 Oct 12, 2021	BUY	$106.4 - $120.78 $92,461 - $104,957	869 Added 6.34%	14,578 $1.57 Million
Q2 2021 Jul 15, 2021	BUY	$105.21 - $117.21 $9,468 - $10,548	90 Added 0.66%	13,709 $1.54 Million
Q1 2021 Apr 26, 2021	BUY	$102.3 - $112.62 $20,766 - $22,861	203 Added 1.51%	13,619 $1.47 Million
Q4 2020 Jan 13, 2021	SELL	$80.49 - $108.67 $16,902 - $22,820	-210 Reduced 1.54%	13,416 $1.44 Million
Q3 2020 Oct 13, 2020	SELL	$85.91 - $100.83 $5,412 - $6,352	-63 Reduced 0.46%	13,626 $1.19 Million
Q1 2020 Apr 09, 2020	BUY	$64.5 - $97.79 $48,375 - $73,342	750 Added 5.8%	13,689 $1.04 Million
Q4 2019 Jan 10, 2020	BUY	$72.13 - $90.25 $6,635 - $8,303	92 Added 0.72%	12,939 $1.15 Million
Q3 2019 Oct 08, 2019	BUY	$62.98 - $75.72 $12,596 - $15,144	200 Added 1.58%	12,847 $973,000
Q2 2019 Jul 08, 2019	BUY	$65.7 - $83.98 $4,139 - $5,290	63 Added 0.5%	12,647 $920,000
Q1 2019 Apr 05, 2019	SELL	$77.14 - $90.79 $20,442 - $24,059	-265 Reduced 2.06%	12,584 $1.01 Million
Q4 2018 Mar 20, 2019	BUY	$77.85 - $96.01 $1 Million - $1.23 Million	12,849 New	12,849 $1.19 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pinnacle Bancorp, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pinnacle Bancorp, Inc. with notifications on news.

Account

Pinnacle Bancorp, Inc. Abb Vie Inc. Transaction History